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It has recently been found that hypertensin may exist in two forms (1). The 
first, hypertensin I, is the initial product of the action of the renal enzyme renin 
upon its plasma substrate. The second, hypertensin II, is produced from hyper- 
tensin I  by the action of an enzyme contained in the plasma  which requires 
chloride ion for its activation. 
Both forms of hypertensin are pressor upon intravenous injection into intact 
animals and give blood pressure responses which do not differ significantly in 
duration or general  contour. The recent work  of Helmer (2), using  isolated 
aortic strips,  suggests that hypertensin II is  a  true vasoconstrictor  material 
while hypertensin I  is not. Experiments have been performed,  using isolated 
perfused  rat kidneys which  show that this is  true.  Hypertensin I  therefore 
becomes pressor upon intravenous injection only as a result of its immediate 
change to hypertensin II by the converting enzyme in the plasma. 
Hypertensin I has been purified by means of countercurrent distribution (3) 
and its quantitative amino acid composition determined (4). It is desirable that 
this material be converted to hypertensin II by means of the converting enzyme 
and that the chemical reaction involved be elucidated.  A method has therefore 
been devised by which the converting enzyme can be prepared in a highly con- 
centrated and partially purified form. 
EXPERIMENTAL 
Perfusion  of the  Isolated  Rat K/dney.--Large  male  rats were  anesthetized with  sodium 
amytal  (9.0  rag./100  gin.)  and the peritoneal cavity opened with a  long midline incision. 
Heparin (1 mg./100 gm.) was given by direct injection into the exposed vena cava. The left 
kidney was freed from its bed, the renal artery exposed, and cannulated in situ with 22 gauge 
needle stock inserted into a short piece of polyethylene tubing. The kidney was then removed 
from the animal and the tubing connected to a positive displacement, variable speed, rubber 
tubing pump which was arranged to deliver a physiological salt solution (5) from a  reservoir 
at any desired rate between 0.8 and 3.2 ml. per minute. A  "T" fitting was inserted in the 
line leading from the pump to the kidney to permit the connection of a  small bore mercury 
manometer equipped  for inkwriting on the kymograph  (6).  This arrangement allowed  the 
recording of the pressure required to force a  constant stream of perfusion fluid through the 
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kidney. No attempt was made to control the temperature of the pedusion. Immediately after 
the connection of the kidney to the pump perfusion was instituted at pressures of 150 to 250 
ram. of Hg for a  period of 15 to 30 minutes in order to wash out all traces of blood. At the 
end of this time the speed of the pump was reduced until the pedusion-pressure was in the 
range of 50 to 100 ram. of Hg. Injections of solutions to be tested could then be made into 
a  rubber tube connecting the pump with the reservoir of fresh perfusate. 
The solutions used for testing were prepared from purified hypertensin I, with a  purity 
of 7150 Goldblatt units (7)  per rag.  of N  and from purified  hypertensin  II  which  had  a 
purity of 13,700  units per rag. of N. Both solutions were prepared in alkaline saline (3) and 
were assayed in the intact rat  (6)  and found to have equal pressor activity. 
As shown in the recording of Fig.  1 the injection of 0.05 units of hypertensin II resulted 
in large and sustained elevations in the perfusion pressure while similar doses of hypertensin 
I  were completely without effect.  In other experiments the dose of hypertensin I  was  in- 
creased twelve times without any evidence of vasoconstrictor activity. 
Preparation of the Converting Enzyme.--Horse  blood was  collected in one-tenth volume 
of 4 per cent sodium citrate, chilled to 0-3°C. and centrifuged as soon as possible. The plasma 
was removed and adjusted to a pH of 6 with 2.5 s  H:SO4 and mixed immediately with one 
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FIO.  1. Perfusion of isolated rat kidney: 1, injection of 0.05 units of hypertensin I; 2, in- 
jection of 0.05 units of hypertensin 1I. Perfusion pressure in ram. of Hg, time in minutes. 
third volume of 4.0 M ammonium sulfate solution. This portion of the procedure was per- 
formed within a  period of 3 hours after the collection of the horse blood. 
Additional  3.5  M ammonium  sulfate  solution was  added  slowly  with  constant stirring 
until the molarity reached  1.6.  A  precipitate formed which was  removed  by filtration on 
large gravity funnels and discarded. The molarity of the ammonium sulfate in the filtrate 
was then raised slowly to 2.2  and the resulting precipitate gathered on Buchner funnels. 
The  1.6 to 2.2 M ammonium sulfate precipitate was dissolved in water and the protein 
concentration of the resulting solution determined and adjusted to 4  per cent. The protein 
solution was reprecipitated twice between the concentration limits of 1.6 and 2.2 u  ammo- 
nium  sulfate.  The  final precipitated protein was  dissolved  in water  to  yield  a  blue-green 
solution which was dialyzed in a  sterilized cellophane bag against cold distilled water until 
it was free of the ammonium ions. Fractions prepared in this fashion contained a considerable 
amount of the converting enzyme but also contained hypertensinase. It was then fraction- 
ated by means of isoelectric precipitation. 
The protein content of the dialyzed solution was adjusted to 2 per cent. The solution was 
chilled to 0-1°C.  and the pH  adjusted  to  5.2  using a  concentrated sodium acetate buffer 
pH 4.0 which resulted in a  light green precipitate that was gathered by centrlfugation. The 
supernatant fluid was discarded. The precipitate was dissolved in 0.05 M sodium phosphate 
buffer at a  pH  of  7.8.  The pale green,  opalescent solution was placed  in ampoules,  shell- 
frozen, and lyophilized. 
This procedure yielded 5.5 gin. of enzyme for every 10 gallons of horse blood. It was free 
of hypertensinase. All  the procedures were  carried  out  at  low  temperatures and  fractions L.  T.  SKEC.,GS~ Jl~.~ ~'.  R.  KAH~  AND  N.  P.  SHUMWA¥  297 
were frozen when not being processed. The converting enzyme was stable at pH 4, although 
it was entirely destroyed in 20 minutes at pH 3 and a  temperature of 25°C. 
Estimation of Enzyme Acti~i~y.--The enzyme was  suitably diluted  so  that  the protein 
content was between 0.025 and 0.25 per cent. It was prepared in a 0.05 ~  sodium phosphate 
buffer with a  pH of 6.5 and a  sodium chloride content of 1 per cent and was sterilized by 
Seitz filtration. 0.2 ml. of a  sterile solution of hypertensin I  containing 100 units was added 
to 9.8 ml. of the buffered enzyme and this mixture incubated for I  hour at 37.5°C.  At the 
end of this period the solution was placed in a  boiling water hath for 10 minutes and after 
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FxO. 2. The enzymatic conversion of hyperten~!n I  to hypertensin II. 
cooling the pH adjusted to 7.  The precipitate which formed was removed by  centrifuging 
and was discarded. A  5 ml. aliquot of the supernatant solution was then subjected to an 8 
tube countercurrent distribution (8) in which the lower phase was composed of 0.1 u  sodium 
phosphate with a pH of 7 containing 15 per cent sodium chloride while the upper consisted 
of redistilled secondary butanol. Tubes 0  and 1 containing hypertensin II were pooled and 
aliquots of both phases removed,  suitably diluted,  and assayed in the rat.  Hypertensin I 
was present in tubes 3, 4, 5, 6, 7 and was treated in a  similar fashion. Tube 2 contained ap- 
proximately 20 per cent of  the total pressor activity, but since previous experiments had 
shown this to be a  mixture of hypertensin I  and II,  it was  discarded.  This experimental 
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of hypertensin I remaining after the action of the enzyme. Hypertensin and the enzyme are 
easily destroyed by bacterial contamination so that it is necessary to conduct these proce- 
dures under sterile conditions. The converting activity cannot be determined accurately in 
crude plasma fractions because of the presence of hypertensinase. 
It was found that the enzyme exhibited its maximum activity at a pH of 6.5 in the pres- 
ence of 0.05 x¢ phosphate. Experiments conducted using 0.1 x¢ citrate and 0.1 x¢ tris(hydroxy- 
methyl)aminomethane indicated that no advantage resulted from the use of either of these 
buffers. In the case of citrate optimai activity was found to be at a pH of 7.5 or higher, while 
the maximum activity was obtained with the tris buffer at a pH of 8. 
Tke Use o/tke Converting Enzyme.--A small scale experiment was conducted prior to the 
conversion of a large amount of purified hypertensin I to hypertensin IL A solution of hyper- 
tensin I containing 710 units per ml. was prepared in a 0.05 ~s sodium phosphate buffer at a 
pH of 6.5. Sodium chloride was added to a concentration of 1 per cent. The solution was 
sterilized by immersion in boiling water for 15 minutes. The lyophilized enzyme was dis- 
solved in a volume of the same buffer so that its concentration was 3 per cent, and was passed 
through a Seitz filter. One volume of the enzyme was added to 6 volumes of the hypertensin, 
and the mixture incubated for 6 hours at 37°C. At suitable intervals during the period of 
incubation small samples were withdrawn from the main incubation mixture. The samples 
were placed on a boiling water bath for 10 minutes and aliquots were taken for eight tube 
countercurrent  distribution  and assay. The ninhydrin reaction was also applied to similar 
aliquots according to the method of Moore and Stein (9). The results of this experiment are 
illustrated in Fig. 2. As the concentration of hypertensin I decreased there was a correspond- 
ing increase in the hypertensin II concentration until at the end of 6 hours 96 per cent had 
been converted. This conversion was accompanied by a corresponding increase in the nin- 
hydrin color value. 
DISCUSSION 
The finding that hypertensin I  is neither a  vasoconstrictor nor a  directly 
pressor substance for the isolated kidney is very surprising because the blood 
pressure responses obtained from the intravenous injection of the two forms of 
hypertensin into intact animals are identical. It must therefore  be concluded 
that the converting enzyme is present in the plasma of test animals in very large 
excess in order that the conversion might proceed at a rate at least equal to that 
of the rate of destruction or utilization of hypertensin II. This example is in 
marked  contrast  to  the  relatively slow  production of  hypertensin I  by  the 
action of renin on its substrate which in all probability is still the rate-limiting 
reaction in the renin-hypertensin  system. 
Inasmuch as  enzymes having peptides  as  their  substrates  are  frequently 
metalloproteins (10) it was of interest to test the effect of cyanide and of versene  1 
upon the  activity of  this  enzyme.  It was  found  that  the  addition of either 
of these substances to incubation mixtures in concentrations of 0.01 x~ caused a 
marked  reduction in  the  amount of  hypertensin converted.  Attempts  were 
therefore made to reduce the activity of the enzyme by electrodialysis and by 
dialysis against 0.005 M cyanide. In neither case was the activity of the enzyme 
preparation decreased  by the treatment. The addition of 8  different metallic 
ions to concentrations  of 0.0001 ~  was also of no value in increasing the activity 
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of the enzyme preparations. Therefore it seems possible that the enzyme is a 
metalloprotein. 
The enzyme has been used to convert a  preparation of hypertensin I  con- 
mining 250,000  units with a  specific activity of approximately 7700 units per 
mg. of nitrogen. After termination of the reaction and suitable removal of the 
enzyme a preparation of hypertensin II was obtained which contained 228,000 
units with a purity of 9900 units per rag. of nitrogen. Since the specific activity 
was actually increased by the process it seems probable that only very small 
amounts of impurities are introduced by the enzyme preparation. 
SUMMARY 
It has been shown by use of isolated, perfused rat kidneys that hypertensin 
II is a  potent vasoconstrictor substance while hypertensin I  is not. Hence it 
would appear that in intact animals the pressor activity of hypertensin I  re- 
sults from its rapid conversion to hypertensin If. 
An  enzyme which  effects this  conversion  has  been  procured  from  horse 
plasma in a semipurified form by means of ammonium sulfate fractionafion and 
isoelectric precipitation. A  method is described for estimating the activity of 
the enzyme. An example of the use of the preparation in converting purified 
hypertensin I  to hypertensin II has been described. 
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